STOCKSURGICAL & MEDICAL INSTRUMENTS & APPARATUSUpdated 2026-08-23
Here’s whether Becton, Dickinson and Co. (BDX) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.65% over 10 days); 3-month momentum positive (+30.1%). Concerns: RSI 85 — overbought, elevated pullback risk. Currently 9.9% off its 52-week high. Score: +4/7.
BDX is in a confirmed uptrend, trading above both its 50-day ($161.40) and 200-day ($171.55) moving averages. With an RSI of 85.3, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -2.4% compares to +20.5% for SPY (trailed the market by 22.8%).
$10,000 invested 1 year ago→ $9,765 today
vs. S&P 500 (SPY) — same period trailed market by 22.8%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($171.55)
✓Above 50-day MA ($161.40)
!RSI(14) neutral zone (30–70) — currently 85.3
✗Positive return (-2.4%)
✓Within 10% of period high (−9.9%)
Period Range $192.00
$140.11$213.08
RSI (14) 85.3
0 · OversoldOverbought · 100
Key Metrics
Price$192.00
Period Return-2.4%
Period High$213.08
Period Low$140.11
Drawdown−9.9%
MA-50$161.40
MA-200$171.55
RSI (14)85.3
Avg Volume (30d)1.8M
vs. SPYtrailed by 22.8%
Return Rank#600 of 999
Trend Signals
Price is above the 200-day moving average ($171.55)
Price is above the 50-day moving average ($161.40)